Connection
Jeffrey Swigris to Protein Kinase Inhibitors
This is a "connection" page, showing publications Jeffrey Swigris has written about Protein Kinase Inhibitors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.337 |
|
|
|
-
Guler SA, Lindell KO, Swigris J, Ryerson CJ. Medications for Idiopathic Pulmonary Fibrosis: IPF Part 2. Am J Respir Crit Care Med. 2021 02 01; 203(3):P7-P8.
Score: 0.116
-
Antoniou K, Kamekis A, Symvoulakis EK, Kokosi M, Swigris JJ. Burden of idiopathic pulmonary fibrosis on patients' emotional well being and quality of life: a literature review. Curr Opin Pulm Med. 2020 09; 26(5):457-463.
Score: 0.113
-
Kreuter M, Wuyts WA, Wijsenbeek M, Bajwah S, Maher TM, Stowasser S, Male N, Stansen W, Schoof N, Orsatti L, Swigris J. Health-related quality of life and symptoms in patients with IPF treated with nintedanib: analyses of patient-reported outcomes from the INPULSIS? trials. Respir Res. 2020 Jan 30; 21(1):36.
Score: 0.108